Abstracts Archive - Page 258 of 1683 - ATC Abstracts

2021 American Transplant Congress
High Levels of Sars-cov-2 Detected in Immunosuppressed Covid-19 Patient Environments Weeks Following Initial Positive Test
C. E. Kuschner¹, Z. Brune², L. B. Becker¹, L. Teperman¹
¹North Shore University Hospital, Manhasset, NY, ²Feinstein Institutes for Medical Research, Manhasset, NY
*Purpose: COVID-19 is a novel viral illness associated with significantly worse mortality, prolonged disease course, and extended periods of viral shedding in transplant patients on…
2021 American Transplant Congress
Liver and Kidney Transplantation During the Covid-19 Pandemic Period: A Single Center Experience
M. Haberal¹, E. Karakaya¹, A. Akdur¹, E. Ayvazoglu Soy¹, F. Ozcay², E. Baskin³, S. Boyacioglu⁴, A. Torgay⁵, S. Yildirim¹, G. Moray¹, F. Yarbug Karakayali¹
¹Division of Transplantation, Department of General Surgery, Baskent University, Ankara, Turkey, ²Department of Pediatric Gastroenterology, Baskent University, Ankara, Turkey, ³Department of Pediatric Nephrology, Baskent University, Ankara, Turkey, ⁴Department of Gastroenterology, Baskent University, Ankara, Turkey, ⁵Department of Anaesthesiology, Baskent University, Ankara, Turkey
*Purpose: Introduction: Beginning of this year, when the Covid-19 pandemic has first started, it had the immediate effect of severely reducing living and deceased organ…
2021 American Transplant Congress
Investigating Physician Outlook Regarding Living Donation Prior to Planned Withdrawal of Care
S. Rath¹, L. Washburn², S. Creden¹, M. Goss³, A. Rana¹, J. Goss¹, N. T. Galvan¹
¹Baylor College of Medicine, Houston, TX, ²University of Pittsburgh Medical Center, Pittsburgh, PA, ³McGovern Medical School, Houston, TX
*Purpose: The aim of this study is to assess the attitudes of physicians, physician assistants, and nurse practitioners in transplant and critical care regarding Living…
2021 American Transplant Congress
Summary of the OPTN’s Policy and System Modifications in Response to the COVID-19 Pandemic
A. Wilk, S. Taranto, C. Jett, L. Cartwright
UNOS, Richmond, VA
*Purpose: In April 2020, the OPTN made several policy and system modifications in response to the growing COVID-19 pandemic including updates to candidate lab data,…
2021 American Transplant Congress
Combined Liver and Lung Transplantation with Extended Normothermic Liver Preservation Using Transmedics Organ Care System (OCS)^TM Liver: A Single Center Experience
J. Konel¹, M. Shamaa², O. Shamaa², A. Elsabbagh², T. Kitajima², T. Ivanics², K. Delvecchio², A. Mohamed², S. Yeddula², K. Collins², A. Yoshida², M. Abouljoud², S. Nagai², M. Rizzari²
¹Wayne State University School of Medicine, Detroit, MI, ²Henry Ford Transplant Institute, Detroit, MI
*Purpose: Combined liver-lung transplantation (CLLT) is indicated in patients who cannot survive single-organ transplantation alone. Ex-situ normothermic machine perfusion (NMP) has been used to increase…
2021 American Transplant Congress
Healthcare Disparities Amongst Dialysis Patients in North Carolina: Decreased Access to Transplant in Lowest Health Rank Counties
D. Leto¹, W. Irish², C. Haisch², B. Tuttle², D. Leeser²
¹Cape Fear Valley Medical Center, Fayetteville, NC, ²East Carolina University, Greenville, NC
*Purpose: This study measured healthcare disparities amongst the counties in North Carolina with the best compared with counties with the worst healthcare outcomes, specifically the…
2021 American Transplant Congress
Baseline Levels of Dd-cf Dna After Pancreas Transplantation: Using Dd-cfdna as an Indicator for Pancreas Rejection and Biopsy Avoidance
A. Yoo, I. Qian, A. Riedel, C. Cazac, A. Bartosic, J. S. Bromberg, J. Scalea
Department of Surgery, Division of Transplant, University of Maryland School of Medicine, Baltimore, MD
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) testing, which has been previously validated for monitoring kidney transplant (KTx) rejection, may provide an alternative to pancreas biopsy that…
2021 American Transplant Congress
The Quality Incentive Program (QIP) is Associated with Increased Waitlisting for Transplantation
J. T. Adler¹, L. Xiang¹, J. S. Weissman¹, J. R. Rodrigue², R. E. Patzer³, S. S. Waikar⁴, T. C. Tsai¹
¹Surgery, Brigham and Women's Hospital, Boston, MA, ²Surgery, Beth Israel Deaconess Medical Center, Boston, MA, ³Surgery, Emory University, Atlanta, GA, ⁴Surgery, Boston Medical Center, Boston, MA
*Purpose: The Centers for Medicare & Medicaid Services (CMS) introduced the Quality Incentive Program (QIP) in 2012, a pay-for-performance program which penalizes dialysis centers payments…
2021 American Transplant Congress
AM PAC Scores and Liver Transplant Resource Utilization
M. Pierpont¹, M. Gosselin², K. Robichaux³, A. Kumar¹, J. Buggs⁴, N. Kemmer⁵
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Honors College, University of Tampa, Tampa, FL, ³Honors College, University of South Florida, Tampa, FL, ⁴Transplant Surgery, Tampa General Hospital, Tampa, FL, ⁵Transplant Hepatology, Tampa General Hospital, Tampa, FL
*Purpose: Activity Measure for Post-Acute Care (AM-PAC) is a tool utilized to assess three functional domains: basic mobility, daily activities, and applied cognition. Previous studies…
2021 American Transplant Congress
Bamlanivimab for Covid-19 in Kidney Transplant Patients
M. Y. Jan, S. El-Sayegh, M. S. Yaqub, D. P. Mishler, O. Adebiyi, M. D. Anderson, T. E. Taber, A. Sharfuddin
Nephrology, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Treatment options for patients with COVID 19 have limited efficacy in reducing severity and duration of viral symptoms as well as progression to severe…